Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 53Breast Neoplasms 13Polycystic Ovary Syndrome 8Infertility 6Ovarian Hyperstimulation Syndrome 3Neoplasms 3Lymphoma 3Sarcoma, Ewing 2Sarcoma 2Prostate Adenocarcinoma 2Osteosarcoma 2Uterine Anomalies 1The Neoadjuvant Therapy 1Sleep Wake Disorders 1Salpingitis 1Salivary Gland Neoplasms 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Neoplasm Metastasis 1Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1Myofibroma 1Metabolic Syndrome 1Leiomyoma 1Infertility, Female 1Hypogonadism 1Hodgkin Disease 1Hematopoietic and Lymphatic System Neoplasm 1Helping Behavior 1Fatty Liver 1Fatigue 1

Interventions

penclomedine 1atezolizumab 1Triptorelin Pamoate 1Orchiectomy 1Olive Oil 1Metformin 1Exenatide 1Excitatory Amino Acids 1Diet, Ketogenic 1Bevacizumab 1Amino Acids, Essential 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fatty Liver × Triptorelin Pamoate × Clear all
NCT02102646 2015-10-28

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Herlev Hospital

Phase 4 Completed
31 enrolled
Genitourinary

Fatty Liver, Hypogonadism, Prostatic Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡